Removing Unnecessary Barriers to Contraceptive Services

Recommendations

Info

Unnecessary Screening Tests: The “Screening Pelvic Exam” • Screening pelvic exam started as a – Method to obtain cervical specimen for CT/GC – Screen for cervical cancer with cytology – Screen for ovarian cancer with bimanual exam • Performed annually because of “yearly Pap smear” strategy until 2003
Summary of Cervical Cancer Guidelines USPSTF 2012 Triple A 2012 ACOG 2012 hrHPV test Under 21 years old 21-29 years old 30-65 Years old [D] Every 3 y Co-test: Q5 Cytology: Q3 None Every 3 y Co-test: Q5 Cytology: Q3 “Avoid” Every 3 y Co-test: Q5 Cytology: Q3 Never Reflex only Co-test or reflex >65 years old Hyst, benign None* None* None* None [D] None None None * If adequate prior screening with negative results Co-test: cervical cytology plus hrHPV test Cytology: cervical cytology (Pap smear) alone
Page 1 and 2: Title X Grantee Meeting July 31, 20
Page 3 and 4: Goals of the Title X Guidance Revis
Page 5 and 6: Clinical Barriers to Contraceptive
Page 7 and 8: MMWR May 28, 2010 Focus on safety i
Page 9: Evidence Based Guidelines for Famil
Page 13 and 14: USPSTF (2012) Ovarian Cancer Screen
Page 15 and 16: Ovarian Cancers: PLCO Cancer Screen
Page 17 and 18: Question 30: What examinations or t
Page 19 and 20: U.S. Selected Practice Recommendati
Page 23 and 24: The “Screening Pelvic Exam” Is
Page 25 and 26: Perceived Problems with Deletion of
Page 27 and 28: E/M Visit: Time Factor • Average
Page 29 and 30: Examinations and Tests Needed Befor
Page 31 and 32: US Medical Eligibility Criteria Cat
Page 33 and 34: Well Woman Preventive Services in F
Page 35 and 36: Well Woman Preventive Services in F
Page 37: How Are Core Family Planning Preven
Page 40 and 41: Routine Cancer Screening in Women A
Page 42: Routine Metabolic Screening Age 18-

Removing Unnecessary Barriers to Contraceptive Services

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?